Relevant clinical factors for early extubation in living-donor liver transplantation: A single-center retrospective cohort study

Table 3 Multivariate analysis of variables associated with early extubation

Variable	Whole group (n = 159)		Subgroup (n = 67)
	Adjusted OR (95%CI)	P value	Adjusted OR (95%CI)	P value
Anhepatic time (hour)	0.439 (0.232-0.831)	0.011	0.344 (0.116-1.018)	0.054
Epidural analgesia (Reference. No)	15.730 (1.919-128.919)	0.010	19.381 (2.153-174.433)	0.008
High-dose vasoactive drug, ES (Reference. No)	0.235 (0.106-0.519)	< 0.001	0.355 (0.091-1.391)	0.137
MELD score	1.000 (0.938-1.066)	0.994	1.080 (0.926-1.259)	0.325
Postreperfusion syndrome (Reference. No)	1.172 (0.402-3.420)	0.771	0.978 (0.171-5.593)	0.980
Total blood products (units/hour)	0.874 (0.592-1.291)	0.499	0.858 (0.410-1.797)	0.685

High-dose vasoactive drug defined as dosage ≥ 0.1 µg/kg/minute of norepinephrine equivalent. OR: Oodd ratio; CI: Confidence interval; ES: End of the surgery; MELD: Model for end-stage liver disease.